NCT02809183View on ClinicalTrials.gov

Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Acidosis
Interventions
DRUG

Placebo

oral suspension

DRUG

TRC101

oral suspension

Trial Locations (5)

Unknown

Investigative Site 1, Sofia

Investigative Site 3, Tbilisi

Investigative Site 4, Tbilisi

Investigative Site 5, Tbilisi

Investigative Site 6, Tbilisi

All Listed Sponsors
lead

Tricida, Inc.

INDUSTRY

NCT02809183 - Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis | Biotech Hunter | Biotech Hunter